Susan Hasty, Publisher
Table of Contents . . . May 31st, 1999
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Conference Coverage (ASCO) - Liposomes Increase Immune Response in Cancer Vaccine
Conference Coverage (ASCO) - Reduced PSA Level Associated with Prolonged Survival
Conference Coverage (ASCO) - Oral 5'-DFUR and MPA Reduce Pain in Cancer Patients
Conference Coverage (ASCO) - Prostate Cancer Responds to Immunotherapy Clinical Trial
Conference Coverage (ASCO) - Retroviral Vector Safe When Given As Multiple Injections
Human Papillomavirus (Treatment) - Nucleoside Phosphonate Analog Suppresses HPV
Breast Cancer (Therapy) - Tamoxifen Urged for At-Risk Women
Conference Coverage (ASCO) - BM Angiogenesis of Prognostic Value in MM
Conference Coverage (ASCO) - Bone Marrow Neo-Angiogenesis in Multiple Myeloma
Conference Coverage (ASCO) - Double Cycle Stem Cell Approach for Metastatic Breast Cancer
Conference Coverage (ASCO) - Nasal Antiangiogenic Agent Effective in Kaposi's Sarcoma
Conference Coverage (ASCO) - Support for Anti-Integrin MoAb Therapy for Kaposi's Sarcoma
Breast Cancer (ASCO Conference News) - Some Cancer Experts Hold Out Hope for Bone Marrow Transplants
Breast Cancer (Therapy) - Drug Combination Found Effective in Treating Advanced, Recurrent Cancer
Breast Cancer (Therapy) - Taxotere Plus Adriamycin Outperforms Standard Combination
Cancer Vaccines (Breast/Ovarian Cancers) - Survival Increased Following Chemotherapy and Stem Cell Transplant
Clinical Trials (Economics) - Costs for Cancer Clinical Trials Comparable to Standard Treatment
Colon Cancer (Pathogenesis) - Scientists Identify Protein That Sets Stage for Cancer in Mice
Colorectal Cancer (ASCO Conference News) - Tumor Characteristics May Help Explain Tumor Biology and Prognosis
Colorectal Cancer (Metastasis) - Technique for Treating Liver Metastasis Improves Survival
Neovasculature (Tumor) - "Cancer-Associated Neovasculature Expresses Prostate-Specific Membrane Antigen (PSMA)."
Antiangiogenesis - "A Phase II Trial of Humanized Monoclonal Anti-Vascular Endothelial Growth Factor Antibody (rhuMAb VEGF) in Hormone Refractory Prostate Cancer (HRPC)."
Antiangiogenesis (Cancer) - "A Phase II Evaluation of Thalidomide in Patients with Metastatic Breast Cancer."
Cancer Gene Therapy - "Engineered Herpes Simplex Virus for Treatment of Gliomas."
Cancer Gene Therapy - "Serum Free Conditions for Retroviral Vector Mediated Transduction of Hematopoietic Cells."
Cancer Immunotherapy - "A Phase I Trial of GP100/Tyrosinase Peptide-Pulsed Dendritic Cells for Metastatic Melanoma."
Cancer Immunotherapy - "Effective In Vivo Anti-Tumor Immune Responses with T7 Vector Transfected Dendritic Progenitor Cells."
Cancer Pain Relief - "A Phase II Study of Irinotecan (CPT-11) as Palliative Therapy in Refractory Advanced Colorectal Cancer (CRC)."
Cancer Vaccines (Prostate) - "A Phase I Trial of Recombinant Prostate Specific Antigen Expressing Vaccinia Virus Vaccine, PROSTVAC (rV-PSA) in Advanced Prostate Cancer."
Clinical Trials (Breast Cancer) - "A Multicenter Phase II Trial of XelodaTm (Capecitabine) in Taxane-Refractory Metastatic Breast Cancer."
Antiangiogenesis - "Lovastatin and Tumor Necrosis Factor-alpha Exhibit Potentiated Antitumor Effects Against Ha-ras-transformed Murine Tumor Via Inhibition of Tumor-Induced Angiogenesis."
Breast Cancer - "A Phase I/II Study of Vinorelbine, Doxorubicin, and Methotrexate With Leucovorin Rescue as First-Line Treatment for Metastatic Breast Cancer."
Breast Cancer - "Double-Phase Tc-99m Sestamibi Scintimammography to Assess Angiogenesis and P-Glycoprotein Expression in Patients With Untreated Breast Cancer."
Cancer Gene Therapy - "Cytosine Deaminase/5-Fluorocytosine Gene Therapy Can Induce Efficient Anti-Tumor Effects and Protective Immunity in Immunocompetent Mice But Not in Athymic Nude Mice."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.